A recently approved preventative migraine drug called atogepant (branded Qulipta) seems to help even the most difficult cases, preliminary research out this week has found. The study showed that patients who hadn’t responded to other treatments experienced noticeably fewer days with migraine while on atogepant than…
Read more…
Source : New Migraine Drug Can Even Tackle the Most Difficult Cases, Study Finds
